TABLE 1

IC50 values of CCR5 antagonists in inhibiting ligand binding and HIV-cell fusion

Data are presented as mean ± S.E.; data were derived from three independent experiments. Kd values are for various ligands binding to the WT CCR5.



Ligand Binding Assay

CCF Assay

Antiviral Assay

125I-RANTES
125I-MIP-1α
125I-MIP-1β
nM
Ligand Kd (nM) 0.59 ± 0.1 1.4 ± 0.5 0.4 ± 0.5
Vicriviroc 14 ± 1 11 ± 8 12 ± 3 1.2 ± 0.4 7.2 ± 2
Maraviroc 9 ± 9 4 ± 1 3 ± 1 1.2 ± 0.5 1.4 ± 1
TAK779 4 ± 5 7.5 ± 5 4.5 ± 1 18 ± 2 13 ± 6
TAK 220 17 ± 5 7 ± 1 4,100 ± 320 6.1 ± 4 3 ± 4
Aplaviroc
12 ± 2
8.5 ± 3
7.3 ± 0.2
1 ± 0.6
1 ± 1
  • CCF, cell-cell fusion.